Stay updated on Pembrolizumab with Radiotherapy in CTCL Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page.

Latest updates to the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe study record page now displays a 403 Forbidden error, replacing the content with an access message and site chrome. This indicates blocked access rather than an update to trial data or page functionality.SummaryDifference19%

- Check14 days agoNo Change Detected
- Check28 days agoChange DetectedNIH grant/contract information was added to the study identifiers. The site revision was updated to v3.6.6 and the previous revision v3.6.5 was removed.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page revision label updated from v3.6.4 to v3.6.5, indicating a minor update to the underlying platform.SummaryDifference0.0%

- Check56 days agoChange DetectedThe study's results status label changed from 'No Results Posted' to 'Results Submitted', indicating that the trial's results have been submitted for reporting and are awaiting posting.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page's revision label updated from v3.6.3 to v3.6.4. This indicates a new build of the page without affecting the study data or displayed content.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page footer now shows Revision: v3.6.3, indicating a platform update that affects the interface but not the clinical trial details.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with Radiotherapy in CTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page.